Mirtazapine Tablets

Award Notice Posted

Solicitation number
VA797P14R0015
Agency
Awarded
to Mylan Pharmaceuticals Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
VA797P14C0016 Federal IDV award
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

Added: Mar 12, 2014 12:56 pm Sources Sought Notice- National Contracts Standardization Program

The purpose of this Sources Sought Notice is for information and planning purposes only and does not constitute a solicitation. Offers are not being solicited at this time. The Government does not intend to award a contract on the basis of this request for information.

The Department of Veterans Affairs (VA) National Acquisition Center is conducting market research to assess industry capabilities for distribution of the Pharmaceutical Drug Mirtazapine, under NAICS Code 325412, to VA and other Government Agencies (OGAs). The VA is seeking responses to this request for information from interested, capable firms that can meet all of the requirements set forth below.

Capabilities should include but are not limited to:

" Is your firm currently selling all the package strengths and package sizes commercially as indicated in the table below?

" Is your firm currently selling all unit of use package sizes with a child proof closure (safety cap) and a bottle with a minimum required size of 100cc volume. The safety cap must not exceed the diameter of the bottle. The bottle must have a cylindrical body and minimum of 5.75" circumference. The bottle must fit a label with dimensions of 5.25" x 2". The 0.5" additional space is required to keep the bar code exposed and/or allow for the display of the expiration date and lot number.

" Is your firm able to provide the estimated annual quantities?

" Would your firm be able to fill an initial order up to 30% of the estimated annual quantities?

" Is your firm able to deliver the product to the VA's Pharmaceutical Prime Vendor no later than 45 days after award?

" If not the manufacturer of the product, is your firm able to provide a Letter of Commitment from the manufacturer?

ITEM DESCRIPTION PKG SIZE (BT)

TOTAL EST ANNUAL USAGE (BT)

1 MIRTAZAPINE 15 MG TAB 30 81,892

2a MIRTAZAPINE 15 MG TAB 500 20,360

OR OR OR OR

2b MIRTAZAPINE 15 MG TAB 1000 10,180

3 MIRTAZAPINE 30 MG TAB 30 205,034

4a MIRTAZAPINE 30 MG TAB 500 25,280

OR OR OR OR

4b MIRTAZAPINE 30 MG TAB 1000 12,640

5 MIRTAZAPINE 45 MG TAB 30 1,305

6a MIRTAZAPINE 45 MG TAB 500 9,328

OR OR OR OR

6b MIRTAZAPINE 45 MG TAB 1000 4,664



Interested and capable respondents able to meet all the requirements of this notice are requested to respond to this notice by providing information to include: company name, address, point of contact, phone number, DUNs number (www.dnb.com), business size, and manufacturer of the drug. Responses will be accepted via email to Iliana Jorge iliana.hernandezjorge@va.gov at your earliest convenience, but no later than March 25, 2014, 2:30pm Central Time.

Files

File Type Posted
VA797P-14-R-0015-000.docx DOCX document

Notice history

Notice Type Posted
Mirtazapine Tablets Mylan Pharmaceuticals, Inc. August 28, 2014 to August 27, 2015 Base Year (with 4 one-year options) Latest Award Notice
This notice Original Award Notice

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity